AGN-745
AGN-745 is a chemically modified siRNA designed to target vascular endothelial growth factor receptor-1 (VEGFR-1), and it is utilized in the research of macular degeneration.
Product Specifications
CAS Number
1255908-66-7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL303096V 500 µL Each
PWWP3B Human shRNA Lentiviral Particle (Locus ID 139221)
Sign In for Pricing
View Details 
MBS6146741-01 0.1 mL
CYLD (Ubiquitin Carboxyl-terminal Hydrolase CYLD, Deubiquitinating Enzyme CYLD, Ubiquitin Thiolesterase CYLD, Ubiquitin-specific-processing Protease CYLD, CYLD1, KIAA0849, HSPC057) (FITC)
Sign In for Pricing
View Details 
MBS6146741-02 5x 0.1 mL
CYLD (Ubiquitin Carboxyl-terminal Hydrolase CYLD, Deubiquitinating Enzyme CYLD, Ubiquitin Thiolesterase CYLD, Ubiquitin-specific-processing Protease CYLD, CYLD1, KIAA0849, HSPC057) (FITC)
Sign In for Pricing
View Details 